Leanne Minall currently serves as Vice President of Science at Phare Bio, where responsibilities include collaborating with scientists at MIT on AI for antibiotic drug discovery, overseeing a translational drug pipeline, and managing fundraising and technical aspects of grants. In addition, Leanne is a consultant for Orion Therapeutics and Sensible Biotechnologies, where roles encompass advising on RNA drug delivery and directing R&D efforts in therapeutic mRNA production. Previous experience includes directing R&D at VxBiosciences and leading projects at Pfizer, including contributions to COVID vaccine development. Leanne holds a Ph.D. in Chemical Biology from the University of Oxford, alongside certifications in biomanufacturing and quality assurance.
This person is not in any teams
This person is not in any offices